Salient Capital Advisors’s Baker Hughes BKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-33,788
Closed -$704K 67
2020
Q4
$704K Hold
33,788
0.04% 61
2020
Q3
$449K Buy
33,788
+8,298
+33% +$127K 0.03% 64
2020
Q2
$392K Sell
25,490
-2,772
-10% -$40.5K 0.02% 57
2020
Q1
$297K Sell
28,262
-12,068
-30% -$227K 0.02% 44
2019
Q4
$1.03M Sell
40,330
-4,202
-9% -$95.5K 0.03% 58
2019
Q3
$1.03M Buy
+44,532
New +$1.04M 0.03% 57

Other funds holding BKR

Salient Capital Advisors's BKR Position: Q1 2021 in Review

Salient Capital Advisors sold out of Baker Hughes (BKR) in Q1 2021, closing a stake of 33,788 shares — an estimated $704K sold.

Salient Capital Advisors first reported a position in BKR in Q3 2019 and held it in 6 quarters. The position peaked at $1.03M in Q4 2019. 544 funds tracked by Wall St. Rank hold BKR as of Q1 2021.

  • Salient Capital Advisors reported no remaining Baker Hughes position as of Q1 2021 after selling out during the quarter.
  • Salient Capital Advisors sold 33,788 Baker Hughes shares in Q1 2021, an estimated $704K.
  • Salient Capital Advisors first reported a position in Baker Hughes in Q3 2019 and held it in 6 quarters.
  • Salient Capital Advisors's Baker Hughes position peaked at $1.03M in Q4 2019.
  • 544 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2021.

Based on Salient Capital Advisors's 13F filing for Q1 2021, filed 6 May 2021.